Data as of Jun 19
| -0.16 / -6.53%|
The 4 analysts offering 12-month price forecasts for Chelsea Therapeutics International Ltd have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 3.50. The median estimate represents a +74.67% increase from the last price of 2.29.
The current consensus among 4 polled investment analysts is to Buy stock in Chelsea Therapeutics International Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.